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Introduction
 Prelabour Rupture of membranes is a common obstetrical problem. It is a significant 
event as it transforms an ordinary pregnancy into a high risk one. Management depends upon 
careful  weighing  of  fetal  condition,  neonatal  intensive  care  facilities  and  presence  of 
complicating factors.  Overall incidence is 5-10%
 Premature Rupture of membranes is defined as “Rupture of membranes prior to onset of 
labour” by Embrey (1953), Flowers (1962), Downley (1958), & Eastman (1966).
 According  to  Prof.  Chauha   &  Arulkumaran  prelabour  rupture  of  membranes  is 
“Spontaneous breach of chorio amnion with release of amniotic fluid with latent period before 
the onset of labour”. 
          Authors like Ianios(1965) and Lebher(1963) diagnose PROM only when a latent period 
of 1-12 hours has elapsed following amniorrhexis occurring at anytime prior to the onset of 
labour, regardless of period of gestation.
            Majority of Cases of PROM – of about 60% occur after 37 completed weeks.  PROM is 
a significant event that transforms pregnancy into a high risk one by increasing maternal and 
neonatal morbidity and mortality.   Maternal complications like Chorioamnionitis, puerperal 
fever are more common in PROM.  Active management of PROM decreases complications and 
associated maternal and neonatal morbidity and mortality. 
Induction of labour is artificial or non-spontaneous initiation of uterine contractions that 
leads to progressive cervical dilatation and effacement resulting in delivery of baby or products 
of conception.
Since early days of 1950’s when Oxytocin was synthesized,  induction of labour has 
become more popular and accepted as an option in the management of PROM.
Misoprostol, a methyl ester of PGE1 is being under trial for past few years in induction 
of labour.  Misoprostol is receiving attention as a cervical modifier and labour induction agent.
This study compares the safety and efficacy of Misoprostol with Oxytocin in labour 
induction in Term Prelabour rupture of membranes. 
AIM OF THE STUDY
The present study is undertaken to compare the safety and efficacy of Misoprostol with 
that of Oxytocin in labour induction in TERM PROM.
The effects were compared between Primipara and Multipara in a selected sample. 
OBJECTIVES: -
1) To study the effect on labour induction and compare the induction – delivery interval 
between 2 drugs.
2) To compare the mode of delivery between 2 groups.
3) To compare the foetal and maternal adverse effects between 2 drug groups.
4) To compare the maternal and foetal outcome between 2 drug groups.
5) To assess the cost effectiveness between 2 drugs.  
                                    REVIEW OF LITERATURE
 ANATOMY
The human foetal membranes is composed of inner amnion and outer chorion (Bourne 
1962)
Amnion is an avascular structure of thickness 0.2 – 0.5mm.  It provides almost all of the 
tensile strength of the membranes. The Amnion at term is a tough and tenacious but pliable 
membrane. The development of the components of the amnion that protects against rupture or 
tearing is vitally important to successful pregnancy outcome. 
            Borne (1962) described five separate layers of amniotic tissues. They are 
1) Single layer of cuboidal epithelial cells.
2) Basement membrane.
3) Acellular compact layer composed of I, III, V interstitial collagens.
4) Row of fibroblast like mesenchymal cells.
5) Acellular zona spongiosa.
Chorion is a thick opaque friable avascular structure of thickness varying from 0.02 – 
0.2mm.
Intact membranes prevents ascending infection as it forms an effective barrier.  They 
maintain a fluid environment on which foetus depends upon for its survival.  They facilitate 
cervical  dilatation  and  effacement.   Membranes  are  rich  source  of  glycerophospholipids 
containing Arachidonic acid, which are precursors of prostaglandins like PGE2 and PGF2α 
AMNIOTIC FLUID
                      Speculative theories about the origin of amniotic fluid: -
1) Initially the fluid is formed from the primitive cells around the amniotic vesicle.
2) Later there is transudate of fetal extra cellular fluid through the skin and umbilical cord.
3) Diffusion to some extent occurs through the amniotic membrane.
4) In second trimester when the skin becomes keratinised fetal urine and secretions from 
tracheobronchial tree contributes to major volume of amniotic fluid.
5) Amniotic fluid volume is about 50ml at 12 weeks, 400ml at 20 weeks, 1000ml at 36 
weeks and 800ml at 40 weeks.
FUNCTIONS    
1) Amniotic fluid cushions and protects the fetus from physical trauma.
2) It distends the amniotic sac and allows further growth and free movement of the fetus.
3) It serves to maintain an even temperature.
4) When appropriately tested, it provides information about fetal maturity. 
5) It promotes surfactant synthesis.
During labour
6) It forms a hydrostatic wedge, which helps in dilation of the cervix.
7) When the membranes are intact, it prevents interference with placental circulation during 
uterine contractions.
8) It prevents ascending infection to the uterine cavity at the end of first stage of labour by 
flushing and bactericidal action.
RISK FACTORS FOR PROM            
  1.REMEDIABLE RISK FACTORS
 1.Cervico vaginitis
 2.Incompetent cervix
 3.Cigarette smoking
 4.prenatal Diagnostic procedures like amniocentesis etc
 5. * Coitus, Mineral and vitamins deficiencies, cervical examinations
             *  Lacks conclusive confirmation
  2. NONREMEDIABLE RISK FACTORS
1. Prior PROM or preterm delivery
2. Prior cervical surgical procedure
3. Vaginal bleeding –abruptioplacentae, placenta previa etc
4. Ehlers Danlos syndrome
5. * Fetal gender (Male)
*  Lacks conclusive confirmation
PROSTAGLANDINS
      The existence of this group of very interesting substances has been known for many years 
and more than a dozen of prostaglandins have been identified. Levels of prostaglandins and 
their metabolites are increased during labor.
      The treatment of pregnant women with prostaglandins by any of several routes of administration 
causes abortion or labour at all stages of pregnancy.
    Prostaglandin treatment of myometrial smooth muscle tissues in vitro causes contractions 
depending upon the prostanoid tested and physiological status of the tissues treated. 
CHEMISTRY
          The   Prostaglandins are derivatives of prostanoic acid. They are family of highly active 
20 carbon fatty acids containing a cyclopentane ring and 2 aliphatic side chains. Depending 
upon the configuration of the 5-carbon ring each belongs to one of the groups A to I. For each 
group a suffix numeral (1,2,or 3) describes the degree of unsaturation (Number of double bonds 
of the side chain).
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           Caution is needed when using any prostaglandin preparation in patients with glaucoma, 
asthma, severe hepatic / renal impairment. No teratogenesis or fetotoxic effects have been 
observed in animal studies.
MISOPROSTOL: -
It is a Methyl ester of PGE1 additionally methylated at C16. It is orally active synthetic 
ProstaglandinE1 analogue. It is extensively absorbed and undergoes rapid de-esterification to 
its free acid, which is responsible for clinical activity. T-max of   Misoprostol acid is 12(+or-) 3 
minutes and terminal half-life of 20-40 minutes. Misoprostol is stable at room temperature.
                                       
          Systemic bioavailablity of vaginally administered Misoprostol is 3 times greater than the 
oral administration.  It stimulates the uterine contraction probably by increasing formation of 
gap junctions in myometrium.  
Side effects of Misoprostol are vomiting diarrhoea, dyspepsia, abdominal pain, fever, 
hyperstimulation  syndrome,  uterine  rupture,  cervical  laceration  and  rarely  anaphylactic 
reactions.
OXYTOCIN: -
It is an octapeptide secreted by posterior pituitary along with ADH.
Pituitary extract was first used in labour in 1909.  Vigneaud in 1963 separated Oxytocin 
and ADH.  Both are synthesized in supra optic and Para ventricular nuclei of hypothalamus and 
stored  in  nerve  endings  in  neurohypophysis.  Oxytocin  was  the  first  polypeptide  hormone 
synthesized and the 1955 Nobel Prize in chemistry was awarded for this (Vigneaud and co-
workers). 
Oxytocin is inactive orally. Plasma half-life is 10 minutes in in-vivo studies. It is rapidly 
degraded in liver and kidney. 
Continuous  intravenous  infusion  of  Oxytocin  shows  first  order  kinetics  with  a 
progressive  stepwise  increase  with  every  increase  in  infusion  rate,  a  steady  plasma 
concentration is reached 40-60 minutes after the alteration of an infusion. Uterine response 
occurs within 3 to 5 minutes of beginning infusion. 
Side effects are water intoxication due to injudicious use, hyper stimulation, 
uterine  rupture,  cervical  lacerations etc  can occur.   Sometimes hyperbilirubinemias seen in 
neonates.  If  aqueous  fluids  are  infused in  appreciable  amounts  along with Oxytocin water 
intoxication can lead to convulsions, coma and even death.   
Oxytocin regimens for stimulation of labour.
 
Regimen Starting  Dose 
(mU/Min)
Incremental 
Dose 
(mU/min)
Dosage 
interval (min)
Maximum 
Dose
(mU/min)
Low dose 0.5-1
1- 2
1
2
30-40
15
20
40
High dose 6 6a, 3,1 15-40 42
a-The incremental increase is reduced to 3mU/min in presence of recurrent Hyper stimulation.
The woman should have direct nursing supervision while Oxytocin is being infused. The goal 
is to effect uterine activity that is sufficient to produce cervical change and fetal descent while 
avoiding uterine hyper stimulation. Contractions must be evaluated continuously and oxytocin 
discontinued if they persist as greater than 5 in 10 minutes or 7 in 15 minutes period; If they 
last longer than 60 to 90 seconds or if the fetal heart rate pattern becomes non reassuring when 
oxytocin is  stopped,  its  concentration in plasma rapidly falls  because the mean half  life  is 
approximately 5 minutes. Either low dose or high dose regimen can be used employing flexible 
dosing schedule based on hyper stimulation.   
Cervical Scoring systems
Bishops’s score (Bishop 1964)
0 1 2 3
Dilatation (cm) 0 1-2 3-4 5-6
Effacement 
(percent)
0-30 40-60 60-70 80+
Station -3 -2 -1/0 +1/+2
Consistency Firm Medium Soft -
Position Posterior Mid-position Anterior -
Modified Bishops’s score (Calder 1974)
0 1 2 3
Dilatation (cm) <1 1-2 2-4 >4
Effacement(cm) >4 2-4 1-2 <1
Station -3 -2 -1/0 +1/+2
Consistency Firm Average Soft -
Position Posterior Mid-anterior - -
Expected problems in Induction
1. Failure to labour induction.
2. Unforeseen disproportion. 
3. Prematurity.
4. Sepsis.
5. Cord compression and
6. Accidental hemorrhage.
Diagnosis of PROM
1. History of leak or sudden gush of fluid from the vagina and a sterile speculum examination may 
reveal the leakage of liquor.
2.The nitrazine Test
It has an accuracy of 90 to 95 percent. It differentiates the alkaline pH of amniotic fluid (7 to 
7.5) and acid pH of vaginal fluid (4-4.5)
3. The fern Test
The fluid is dried on a slide and observed under microscope. Fern pattern is seen due to crystallization 
of sodium chloride in amniotic fluid
4.The Nile blue Sulphate Test
The presence of desquamated cells from the fetal skin, which stains orange, indicates ruptured 
membrane.
5.Intra amniotic dye instillation
Instillation of indigo carmine, Evans blue, sodium flourescein and examination of vaginal fluid 
on pad for the presence of dye after the few hours is useful.
6.AMNIOSCOPY
                   It may reveal the absence of membranes. This is not done routinely.
7.DIAMINE OXIDASE TEST
                                      Diamine oxidase is produced by decidual cells, enters amniotic fluid and can be 
detected by paper strips.
8. Heat Test
 Endo cervical material is heated on a glass slide and the color of the residue is noted. A white residue 
indicates the presence of amniotic fluid and a brown one indicates its absence.
9.Measurement of alpha feto protein in vaginal fluid is a recent test.
10.Monoclonal antibodies to fetal fibronectin or used to detect the presence of amniotic fluid in 
vaginal secretions.
11.ULTRA SOUND 
To know the amount of liquor left behind and for fetal maturity, USG is done.
Management
Spontaneous rupture of membranes occurs relatively frequently. Reported incidence of 
PROM  Varies  between  2-18%.  (Lebterz  1964,  Sanyal  it  al)  Overall  about  10%  of  the 
pregnancies are complicated by PROM. Of these 60% occur in term pregnancies. 
 Early and increase in rise in perinatal morbidity with an increase in latent period makes 
early decision mandatory.  There should be no delay in immediate induction if foetus is judged 
to have good chance of extra uterine survival. 
 There are two problems in term PROM with unfavourable cervix – 1.  Risk of infection 
when induction is postponed.  2.  Failed induction resulting in increased caesarean section rate.
     Algorithm for management of a term patient with PROM.
Confirm diagnosis by direct visualization of pooling of amniotic fluid, ultra sound
 
Assess cervix by sterile speculum and digital examination
Assess maternal and fetal well being 
Favourable cervix   - Medical or obstetric complications  Unfavourable 
cervix
                       - Unstable fetus
Induction of labour                 Deliver
and deliver
Immediate Induction Expectant management
1 Minimize vaginal examination                               1 Observe for infection &
2 Anticipate long latent phase of labor                    2 for spontaneous onset of labor
          
            Evaldson et al 1980 found that patients delivered 24 hours   after PROM  had 
significant risk of infection.  Infection is related to PROM, number of vaginal examinations, 
time taken between first PV and delivery and Caesarean section.
Unless the mother is grossly neglected mortality due to PROM should not occur. Even 
morbidity is almost negligible. But still development of chorioamnionitis or overt infection is 
associated with higher maternal morbidity and rarely death.
In the presence of infection abnormal labour pattern are common and the chances of 
operative delivery are increased. Rarely uncontrolled infection may lead to septicemia, shock, 
DIC, ARDS and ultimately maternal death.
 
           Neonatal risks are due to infection, complications during labour and delivery.  Higher 
incidence  of  LSCS for  foetal  distress  is  found  in  patients  with  PROM 7-9%.  Analysis  of 
electronic foetal heart rate patterns in patients with foetal distress revealed that these patterns 
are consistent with umbilical cord compression. 
Though the problem of PROM was identified centuries ago the cause is yet unknown, 
management is controversial and the outcome is equivocal.
Karim et al 1972 was the first one to use prostaglandins for induction of labour. They 
used  prostaglandins  intravenously.  In  1973  various  local  preparations  of  PGE2  have  been 
applied to the vagina and the cervix in the form of gels, tablets and pessaries. Misprostol is 
available as 100 μg, 200μg tablets for treatment of peptic ulcer.  It was first reported in 1987 
for induction of labour in case of intra uterine death in third trimester.  It has been extensively 
investigated in past few years for use in cervical ripening and labour induction. 
Luis Sanchez – Ramos, Anita H – Chen and Colleagues 1997 found that Misoprostol 
usage significantly reduces Induction – delivery interval in labour Induction in term PROM 
patients and concluded that vaginal Misoprostol is effective, cheap and safe.
Wing and collaborators reported 50 μg oral Misprostol was less effective than 25 μg 
vaginal Misoprostol for labour induction and 100 μg oral tablet was as effective as 25 μg of 
vaginal Misoprostol. 
 Luis Sanchez – Ramos and associates 1993 compared safety and efficacy of intravaginal 
Misoprostol vs intravenous Oxytocin infusion for labour induction and they reported shorter 
induction delivery interval with Misoprostol in Vaginal delivery group – 11 hrs Vs 18hrs.  In 
74% of patients only one 50µg dose of Misoprostol resulted in successful labour induction.
 .
 
             Miriam Zieman and associates in 1997 studied the absorption kinetics of oral Vs 
Vaginal Misoprostol and found that system bioavailability of Vaginal administration is higher 
than that of oral administration.
 Evita Fernandez, Suseela Varila [2001] conducted a randomized prospective study of 
Misoprostol (50 mcg) for term labour induction.  Average induction delivery interval was 10.34 
hrs.  Caesarean rate was 29%. Tachysystole occurred in 21/200 women of which 15 patients 
were delivered by caesarean section. 
 In Dec 2000 ACOG reaffirmed its recommendation for the use of Misoprostol because 
of proven safety and efficacy.  The committee on obstetrics recommends 25µg intravaginal 
dose.   (William’s  obstetrics  22nd Edn.).  Such usage is  considered to  decrease  the  need for 
Oxytocin, achieve higher rates of vaginal delivery and significantly reduce induction-delivery 
interval.
           
               Kadanalis and kumtupe [1996] in their study on term labour induction with 
Misoprostol  vs  Oxytocin/PGE2  found  that  drug  induction  delivery  interval  was  shorter  in 
Misoprostol group 9.2± 2.4 hours P=0. 001.There was a higher prevalence of cesarean section 
for  failed  induction  in  the  Oxytocin/PGE2group  than  in  the  Misoprostol  group  (13.4  vs 
6.3%)P<0.001. Neonatal outcomes of both groups were also similar.
 Mundle WR, Young DC 1996 in their study of vaginal Misoprostol in labour induction 
concluded  that  induction  –  delivery  interval  was  shorter  in  Misoprostol  group.   Neonatal 
outcomes were similar and Misoprostol is cost effective.
 Merrell DA, Koch MA 1995 in their study of Misoprostol in second and third trimester 
pregnancies found that Misoprostol is effective, easy to use, cheap and safe.
 Kramer  RL,  Gilson  GJ  and  Colleagues  1997  in  their  randomized  trial  of 
Misoprostol(100μg every 4 hours vaginally) and Oxytocin for induction of labour found that 
induction delivery interval is shorter(585minutes vs 885 minutes, P<0.001) in the Misoprostol 
group.Uterine tachysystole was more common and hospital charges were less  with Misoprostol 
group.
 Orane JM in 2003, in his study found that Vaginal PGE1 results in higher rate of vaginal 
delivery within 24hours and increased satisfaction in mothers.
 Fabiana da  graca,  Jose  Cecatti  and Colleagues  in  their  study (Sep 2005)  found that 
Misoprostol  is  associated  with  shorter  latency  period,  shorter  maternal  hospitalization  and 
increased  occurrence  of  alterations  of  contractility  without  maternal,  neonatal  adverse 
outcomes.
 Wing DA, Paul RH (1997) in their study found that induction – delivery interval was 1 
hour  longer  in  Misoprostol  group  and  no  difference  in  tachysystole/  hypertonus  / 
hyperstimulation between two groups and concluded that Misoprostol is an effective alternative 
to Oxytocin in induction of labour in PROM beyond 36 weeks.
 Lin MG, Ramsey PS in their  Meta analysis  –Misoprostol  for  induction of labour in 
women with term PROM (2005) concluded that Misoprostol is an effective and safe agent for 
induction  of  labor  in  Term PROM.  When  compared  to  Oxytocin,  the  risk  of  contraction 
abnormalities and the rate of maternal and neonatal complications   were similar between 2 
groups.
M.S Urala, Lavanya Roy (2001) studied the effect of single dose Misoprostol 50μg for 
induction of labour. In this study 86 women requiring induction of labour were enrolled, 69.7% 
delivered vaginally. Induction delivery internal was 9.09hours and incidence of tachysystole 
was 9.3%.
Peter Danielien et al (1999) studied Misoprostol for Term Labour Induction. Single 
blind randomized comparative trial was carried out with 50μg, 4th hourly Misoprostol and 1mg 
6th hourly Dinoprostone. Misoprostol group had a significant reduction in induction – delivery 
interval and more women were delivered vaginally. There were no adverse neonatal outcomes 
associated with use of Misoprostol.
      Suk wai Ngai, Yik ming chan – 2000 conducted prospective randomized study on 
“Misoprostol (100μg orally every 4 hours) Vs Oxytocin in women at term with prelabour 
rupture of membranes” and concluded that oral Misoprostol caused earlier peak uterine activity 
compared with Oxytocin (6 – 8 hours vs. 8- 10 hours). Both Oxytocin and oral Misoprostol 
caused an increase in uterine activity within one hour of labor induction. Peak uterine activity 
was reached 6-8 hours after oral Misoprostol with persistent effects, and 8-10 hours after 
Oxytocin, requiring continuous titration of medication. The duration of labour was significantly 
reduced in nulliparouswomen, but not in those who were multiparous in the Misoprostol group. 
The induction-to-delivery interval, the mode of delivery, the perinatal outcome were similar for 
the two groups. Oral Misoprostol was not only as effective as Oxytocin in inducing labour in 
women at term with prelabour rupture of the membranes, but it reduced significantly the 
duration of labour in nulliparous women. 
MATERIALS AND METHODS.
SETTING: -
This  study  was  carried  out  in  the  Institute  of  Obstetrics  and  Gynecology,  Madras 
Medical College, Chennai. 
STUDY DESIGN: -
Prospective randomized control study 
STUDY PERIOD: - July 2004 – Feb 2006
SAMPLE SIZE: - Determined by statistical analysis.  Statistical analysis was done using chi 
square test and student ‘t’ test used in appropriate places. About 200 women were randomized 
to either Misoprostol or Oxytocin.
Diagnosis  of  prelabour rupture  of  membranes  made on the  basis  of  history,  clinical 
examination, and speculum examination and confirmed with USG.
INCLUSION CRITERIA: -
1. Singleton pregnancy 
2. Cephalic presentation 
3. Bishop’s score < 4
4. Completed 37 weeks of gestational age 
5. Live fetus showing no signs of fetal compromise on admission CTG.
EXCLUSION CRITERIA: -
1. Multiple pregnancy 
2. Non cephalic presentations
3. Bishop’s Score > 4
4. H/o previous scar, Uterine Surgery 
5. Any medical Conditions complicating Pregnancy 
6. Hydramnios, IUGR, Gestational age < 37 weeks 
7. Women in labour
8. Suspected chorioamnionitis  
 
At the time of entry into study name, age, status of booking, immunization, menstrual 
history, marital history, obstetrical history, medical and personal history were noted down. 
General  Condition  is  assessed  by  pulse  rate,  Blood  Pressure,  Height,  Weight  with 
particular  attention  to  pedal  odema,  anemia.  Cardiovascular  and  respiratory  systems  were 
examined.   Obstetrics  examination includes  size  of  uterus,  lie,  presentation,  attitude,  foetal 
heart sound and rate, liquor adequacy and estimated foetal weight Pelvic examination was done 
to  rule  out  cephalo  pelvic  disproportion  and for  Bishop’s  scoring.    USG done  for  foetal 
maturity, Liquor status and for foetal well-being. Admission CTG done.
METHODS OF APPLICATION: -
MISOPROSTOL: -
Informed consent obtained for Misoprostol group of patients.  In dorsal position 25 μg 
of Misoprostol inserted into posterior fornix and patient is advised to lie down in left lateral 
position for 30 minutes.   Dose is repeated at the interval of 6hrs to the maximum of 3 doses.
OXYTOCIN :-
As Infusion pump in not available,  Oxytocin infusion started intravenously in either 
Normal  saline/Ringer  lactate  at  dose  of  8  drops/mt  (5mU/mt)  incremented  at  30  minutes 
interval to the maximum of 48 drops/mt (30 mU/mt) and monitored with Oxytocin chart  
For all  patients  progress of  labour was monitored with partogram. During induction 
following parameters are monitored.
1. Maternal pulse rate, temperature, blood pressure, and urine output.
2. Uterine contractions for their frequency, duration and strength.
3. Fetal heart rate.
4. Onset of various stages of labour.
          Duration of labour and mode of delivery were notified. Caesarean section was 
resorted to whenever fetal distress arises or for failed induction or for failure to progress 
with  minor  degrees  of  cephalo  pelvic  disproportion.  Babies  were  followed  up  in 
neonatal unit, whenever they got admitted. Mother and baby were discharged in good 
condition and followed up to six weeks. 
  After delivery when mother and baby were discharged from hospital, advice was given for 
postpartum follow up.  Clinical evaluation of mother and foetus was scheduled at 2 weeks after 
delivery and followed upto 6 weeks.
OBSERVATION
(I) AGE DISTRIBUTION:-
Age
In
Years
Misoprostol
(100)
Oxytocin
(100)
No. Of Pts. % No. Of Pts. %
≤ 20 32 32% 13 13%
21 - 30 66 66% 83 83%
< 30 2 2% 4 4%
X ² = 10.63, P = 0.004
1. Distribution of patients under the age group ≤ 20 years is significantly more in 
Misoprostol group (32%) compared to Oxytocin group (13%).
2. Distribution of patients in age group between 20-30 years is significantly more in 
Oxytocin group (83%) compared to Misoprostol group (66%.)
3. Mean age between 2 groups is not statistically significant p = 0.2, t = 1.27.
ii. Height distribution
Height
In
Cms
Misoprostol
(100)
Oxytocin
(100)
No.of Pts. % No.of Pts. %
< 150 13 13% 14 14%
150 – 100 69 69% 71 71%
< 160 18 18% 15 15%
 No statistically significant differences observed between the two groups. 
X ² = 0.34, P = 0.84
iii. Parity distribution:
Parity
Misoprostol
(100)
Oxytocin
 (100)
No.of Pts. % No.of Pts. %
Nullipara 76 76% 75 75%
Para 1 23 23% 22 22%
≥ Para 2 1 1% 3 3%
 Parity wise no statistically significant difference observed between two groups. X ² = 
1.34, P = 0.59
iv.  Gestational Age Distribution: -
GA
Misoprostol
(100)
Oxytocin
(100)
No.of Pts. % No.of Pts. %
37– 40 WKS 99 99% 100 100%
40– 42 WKS 1 1% - -
≥ 42 WKS - - - -
Not much statistical difference observed between the two groups. 
X ² = 0.01, P =1
v.  Bishop Score distribution
Bishop Score
Misoprostol
(100)
Oxytocin
(100)
Nullipara Multipara Nullipara Multipara
Mean 4 4 4 4
No Statistical difference between the two groups.
vi.  No. Of doses of 2 drugs
No. Of doses Misoprostol Oxytocin Total
1 64 78 142
2 36 22 58
Total 100 100 200
vii.  Outcome: - Mode of delivery
Mode of 
delivery
Misoprostol
(100)
Oxytocin
(100)
Nulli 
para
(76)
% Multi 
para
(24)
% Nulli 
para
(75)
% Multi 
para
(25)
%
LN 65 85.56 22 91.67 57 76 23 92
LSCS 9 11.84 2 8.33 16 21.4 2 8
Out let 
forceps
2 2.6 - - 2 2.6 - -
Total 76 100% 24 100% 75 100% 25 100%
1. For  Primipara  vaginal  delivery  in  Mispostol  group is  –  85.56% LN+2.6% outlet 
forceps and in Oxytocin group – 76% LN +2.6% outlet forceps. But this difference is 
statistically not significant. P = 0.38.
2. Incidence of LSCS for primipara in Misoprostol group is (11.84%) and in Oxytocin 
group is (21.5%.). But this difference is statistically not significant p=0.48
For  multipara  no  significant  difference  was  observed  between  two  groups  either  in 
vaginal delivery or in incidence of LSCS.
INDUCTION-DELIVERY INTERVAL:
I – D interval 
Duration in 
hours.
Misoprostol
(100)
Oxytocin
(100)
Nulli 
para
(76)
% Multi 
para
(24)
% Nulli 
para
(75)
% Multi 
para
(25)
%
< 12 66 86.84 22 91.66 52 72.22 23 92%
12 – 24 1 1.31 - - 7 9.33 - -
 > 24 - - - - - - - -
Primipara         “P” = 0.001 Multipara  “P” = 0.63
(Significant) (Non-significant)
1. Mean induction delivery interval  in Misoprostol  group for  nullipara  is  8.5  hrs.   For 
multipara it is 6.6 hrs.
2. Mean  induction  delivery  interval  in  Oxytocin  group  for  nullipara  is  10:4  hrs.    In 
multipara it is 6.5 hrs.
3. Mean induction delivery interval for primipara is significantly reduced in Misoprostol 
group compared to syntocinon group. P = 0.001.
4. No statistically significant difference is observed for multipara between both the groups 
p = 0.63.
ix. PROM – Admission interval
PROM – 
Induction 
interval
Misoprostol
(100)
Oxytocin
 (100)
Primipara (76%) Multipara (24%) Primipara 
(75%)
Multipara 
(25 %)
< 6 hours 34 44.73% 6 25% 31 41.33% 11 44%
6 – 12 hours 40 52.63% 18 75% 42 56% 14 56%
 > 12 hours 2 2.63% - 2 2.66% -
Mean Misoprostol
(100)
Oxytocin
(100)
Std. Deviation t – test
1. PROM-
Induction
interval
8.6 hours 8.2 hours
2.  PROM – 
Delivery 
interval
11.68hours 13.11hours 2.326(M)
2.881(S)
t  = 4.42
P  - 0.001
1. Mean PROM –Admission interval is not statistically significant between both groups. 
For Misoprostol it is 8.6hrs and for Oxytocin 8.2 hrs.
2.But mean PROM – delivery interval is 11.08 hours in Misoprostol group as against 13.11 
hours in Oxytocin group, which is statistically significant.  t   test – t= 4.42 , p = 0.001
x.  INDICATION FOR LSCS: -
Indication for 
LSCS
Misoprostol Oxytocin
Nulli
para
(76%)
%
Multi 
Para
(24%)
%
Nulli
para
(75%)
%
Multi 
Para
(25%)
%
Failed 
induction
3 3.95 - - 8 10.66 - -
Fetal Distress 4 5.26 1 4.16 4 5.33 2 8
Failure to 
progress 
C    CPD I°
2 2.63 1 4.16 4 5.33 - -
Total 9 11.84 2 8.32 16 21.22 2 8
P=0.59
1. Failed induction as an indication for LSCS, is more in Oxytocin group (10.66%) than in 
Misoprostol group (3.95%). But this is statistically not significant.
2. Foetal distress incidence is not statistically different between Misoprostol group (9.42%) 
and Oxytocin (13.3%)
xi.   Birth weight distribution: -
Birth weight
(1Kg)
Misoprostol
(100)
Oxytocin
(100)
Nullipara
(76)
Multipara
(24)
Nullipara
(75)
Multipara
(25)
Mean 2.83 2.86 2.78 2.8
P = 0.28
Not statistically significant
xii. Meconium Stained Liquor: -
Presence of
Meconium 
Misoprostol
(100)
Oxytocin
(100)
Neonatal 
Outcome
Thick 6 8 Good
Thin 10 12 Good
P=0.52
1. In Misoprostol group, 6 patients were with thick meconium stained liquor, 
10 Patients were with thin meconium stained liquor.  All are NST reactive.   Of 6 thick 
meconium stained liquor patients, 5 were not in active phase labour and went in for 
LSCS and one patient in advanced labour delivered by outlet forceps.  All patients with 
thin meconium stained liquor delivered vaginally.  
2.  In Oxytocin group, 8 patients were with thick meconium stained liquor, 12 patients 
were with thin meconium stained liquor.  All are NST reactive.  Of 8 thick meconium 
stained liquor patients, 6 were not in active phase of labour and went in for LSCS, 2 
patients  in  advanced  labour  delivered  by  outlet  forceps.   All  patients  with  thin 
meconium stained liquor delivered vaginally.  
3. Neonatal outcomes were good in both groups.
xiii. APGAR: -
X ² = 3.08  “P” = 0.55 for Apgar at 1 mt
X ² = 4.97   “P” = 0.29 for Apgar at 5 mts
No Statistical difference between two groups in Apgar score 
xiv. NICU ADMISSION: -
Apgar
Misoprostol Oxytocin
Nulli
para %
Multi 
Para %
Nulli
para %
Multi 
Para %
<4 at 1mt - - - - - - - -
4-6at 1mt 8 10.52 1 4.16 9 12% 1 4
> 7 at 5mts - - - - 2 2.66 -
Misoprostol
(100)
Oxytocin
(100)
Nullipara Multipara Nullipara Multipara
NICU Admission 
1LBW
2
       1
Mild 
Resp. 
Distress
1- Mild 
     Resp. 
  Distress
5- Mild 
Resp. 
Distress
6
1 LBW
-
Death - - - -
X ² = 2.25 “P” = 0.69
No statistical difference in NICU admission between two groups.
xv.  Maternal Complications: -
Maternal complications Misoprostol Oxytocin
(100) (100)
Vomiting 1 -
 X ² = 1.01    P = 0.32
1. One patient in Misoprostol group had one episode of vomiting, but no other side effects.
2. No significant difference between two groups in maternal complications.
DISCUSSION
 PROM is a common indication for induction of labour.  Oxytocin and prostaglandins are the 
most frequently used agents.  Success of Oxytocin depends upon condition of cervix at beginning 
of induction. With Prostaglandins, the advantage is promotion of both cervical ripening and 
myometrial contractility.  But the drawback is hyper stimulation syndrome and also frequent 
administration of vaginal Prostaglandins may increase the risk of ascending infection.
This study compares the safety and efficacy of Misoprostol with Oxytocin. Of 200 
patients, each 100 patients were randomized to Misoprostol and Oxytocin group.  Outcomes 
were measured in relation to Induction – delivery interval, mode of delivery, side effects, 
maternal and neonatal morbidity and cost effectiveness.
 The  latency  period  and  time  from  recruitment  until  delivery  were  significantly 
shorter in primipara in Misoprostol group compared to Oxytocin group in the present study. 
Induction delivery interval for primipara in Misoprostol group is 8.5 hours and in Oxytocin 
group it is 10.4 hours. P= 0.001. For multipara, induction-delivery interval in Misoprostol 
group  is  6.6  hrs  and  in  Oxytocin  group  is  6.5  hrs.  P=0.63.  This  is  comparable  to  the 
following studies.
S.No Studies Induction Delivery 
Interval (hrs)
     Present study: 
Induction  Delivery 
Interval (hrs)
1 Fabiana  de  graca  & 
colleagues (2005)
 11
P=0.001
2 Kadanalis, Kumtupe 1996 9.2(+ or -) 2.4
P=0.001
3 Sanchez  and  Ramos  and 
colleagues. 1993.
11
P=0.004
4 Kramer  RL,  Gilson  GJ  and 
Colleagues 1997
585 minutes
P=0.001
5 Chuck FJ, Huffaker- 1995 11.4
P=0.001
8.06
P=0.001
         Vaginal delivery incidence observed for primipara in Misoprostol group is 88% 
compared to Oxytocin group 78.6 %. Prevalence of LSCS in Misoprostol group for 
primipara is 11.84%, and for multipara is 8.34% and in Oxytocin group, for primipara it 
is 21.4%and for multipara it is 8%. However this difference is statistically not 
significant.
         This is comparable to the following studies.
S.NO Studies Caesarean Rate Present study
1. Fabiana de graca
Collegues(2005)
20%
P=0.22
20.17%
P=0.27
2. Kadanalis,kumtepe 
1996
30%
3. Kramer RL, 
Gilson GJ and 
Colleagues
(1997) 
8%
P=0.2
4. Wing DA;Paul RH 
(1996)
20.8%
 In the present study neonatal outcomes were similar.                                                    
           In Misoprostol group, six patients were with thick meconium stained liquor.
           A 20 year old primi / 39 weeks of gestational age/ on admission with clear liquor, had 
thick meconium stained liquor on 2nd dose of Misoprostol and in early phase of labour (NST 
reactive) went in for LSCS.
            Similarly three primipara with term gestation on admission with clear liquor,had thick 
meconium  stained  liquor  on  2nd dose  of  Misoprostol  and  in  early  phase  of  labour  (NST 
reactive) went in for LSCS.
    
           A 25 year old second gravida (G2P1L1), previous full term normal delivery with 40 
weeks gestational age had thick meconium liquor on 2nd dose of Misoprostol and in latent phase 
of labour (NST reactive) went in for LSCS.
           A 29year old primi with term gestation had thick meconium with 1st dose of Misoprostol 
and in active phase of labour delivered by outlet forceps.
      In Oxytocin group eight patients were with thick meconium stained liquor.
     
     Four primi para with term gestation on admission with clear liquor had thick meconium 
stained liquor with Oxytocin. Infusion and latent phase of labour (NST reactive) went in for 
LSCS.
 
        Two-second gravida with term gestation on admission with clear  liquor  had thick 
meconium liquor after Oxytocin. Infusion and in latent phase of labour (NST reactive) went in 
for LSCS.
          Two primipara with thick meconium liquor in active phase of labour were delivered by 
outlet forceps.
            Two babies got admitted in NICU in Misoprostol group-one for low birth weight 
(2.1kg) and other  baby for  mild respiratory distress  (APGAR7/10,8/10) for  observation.  In 
Oxytocin six  babies  got  admitted-one for  low birth  weight  (2kg) and five  babies  for  mild 
respiratory distress for observation. All babies were discharged in good condition.
                   
  
Following studies supports this.
1. Fabiana da graca, Jose Cecatti and colleagues Sep 2005. BJ OG vol 112, 1284 – 1290, 
Sep 2005.
2. Sanchez and Ramos and colleagues 1993 & 1997 Int J Gynaecology obstet 1993 Mar 
81:3, 332-6 1997 April obstet  Gynaecol 89:4, 133-42
3. Kadanalis, Kumtupe 1996 Int I obstet Gynaecol 1996, 55:2, 99-104
4. Windrim R. Bennett K and Colleagues 1997 Obstet Gynaecol 1997 March 89:3, 392 –7.
5. Sukwai ngai, Yikming chan 2000 BJ OG 107 – 222 – 227
           In  this  study,  one  patient  had  vomiting  of  one  episode,  which  resolved 
spontaneously.  No  other  side  effects  were  observed.  And  there  is  no  statistically 
significant difference was observed in adverse effects between two drug groups.
 This is supported by the following studies.
1. Fabiana da graca, Jose Cecatti and Colleagues – Sep 2005 BJ OG Vol 112, 1284 – 1290 
Sep 2005.
2. Sanchez and Ramos and Colleagues – 1993 & 1997 Int J Gynaecol Obstet 1993 March 
81:3, 332-6 .1997 April obstet Gynaecol 89:4, 133-42.
3. Kadanalis, Kumtupe 1996 Int J Gynaecol Obslet 1996, 55:2, 99-104
 4. Sukwai ngai, Yik ming chan 2000 BJ OG 107 – 222 - 227
      Misoprostol is cost effective.  25 µg of Misoprostol costs about 3.81 – 4.25 Rupees. 
Supportive studies are
1.  Mundle WR, Young DC 1996 Gynaecol Obstet 1996 
     Oct.88:4  521-5
2.  Chuck FJ, Huffaker BJ 1998 AMJ Obstet Gynaecol  1998 Oct 173:4  1137-42
No significant  differences  observed in  terms  of  tachysystole  /  Hyper  tonus  /  Hyper 
stimulation between two drug groups.
                                               
Supportive studies are as follows.
1.  Wing DA, Paul RH 1999 AMJ Obstet Gynaecol   1999 Jan 180, 253-4.
2.  Lin MG, Ramsey PS and Colleagues in their metaanalysis of Misoprostol for  
     labour induction in women with term PROM.
3.  Sanchez and Ramos and Colleagues 1993 & 1997 Int J Obstet Gynaecol   
     89:4, 133-42.
 This powerful little tablet (Misoprostol) can work wonder and save time, energy and 
money for many but has to be used with caution and respect.
                                            SUMMARY:-
1. Misoprostol at 25µg dose repeated 6th hourly is an effective, cheap, safe and easy to 
use labour induction agent.
2. Induction – delivery internal is shorter in primipara in Misoprostol group compared 
to Oxytocin group.
3. For multipara, no significant difference in Induction – delivery interval is observed 
between both the groups.
4. No statistically significant difference was observed in caesarean section rate between 
two drug groups.
5. Neonatal outcomes were comparable between both groups.
6. Maternal complications were not significantly different between both groups.
7. No increased incidence of tachysystole / Hyper tonus  / Hyper stimulation observed.
8. Misoprostol is cost effective, easy to use and stable at room temperature.
CONCLUSION 
           
Misoprostol is an effective, cheap, safe, stable at room temperature and easy to 
use if it is used in appropriate dosage for induction of labour in prelabour 
rupture of membranes at term.
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